Labcorp receives emergency use authorization for at home collection kit for combined covid-19 and flu detection

Burlington, n.c.--(business wire)--labcorp (nyse: lh), a leading global life sciences company, today announced that it received emergency use authorization (eua) from the u.s. food and drug administration (fda) for a combined home collection kit that detects covid-19 and influenza a/b simultaneously in individuals as young as 2 years of age. the kit will be available at no upfront cost to those who meet clinical guidelines, which may include experiencing symptoms, being exposed to someone with
LH Ratings Summary
LH Quant Ranking